Technologies assessed | (a) General examination with pulse oximetry (b) General examination |
Population | Term newborns in Colombia Demographical growth as from DANE projections Epidemiological information (prevalence of CCHDs) taken from SLR |
Perspective | Health systemāthird payer |
Time horizon | Every scenario: 1Ā year Three scenarios are compared |
Costs included | See TableĀ 3 (costs associated to the detection of CCHD) The base case corresponds to the current scenario, without the use of pulse oximetry |
Sources of information | Costs deriving from the economic assessment Prevalence derived from SLR |
Scenarios | Current scenario: pulse oximetry: 0% New scenario a: pulse oximetry 10% New scenario b: pulse oximetry 20% |
Results | The difference among estimated scenarios (current and new), expressed as follows: Budget impactā=āNew scenarioācurrent scenario |